InvestorsObserver
×
News Home

Is IRIDEX Corporation (IRIX) a Winner in the Healthcare Sector?

Tuesday, September 05, 2023 10:53 AM | InvestorsObserver Analysts

Mentioned in this article

Is IRIDEX Corporation (IRIX) a Winner in the Healthcare Sector?

IRIDEX Corporation (IRIX) is around the top of the Healthcare sector according to InvestorsObserver. IRIX received an overall rating of 59, which means that it scores higher than 59% of stocks. Additionally, IRIDEX Corporation scored a 73 in the Healthcare sector, ranking it higher than 73% of stocks in that sector.

Overall Score - 59
IRIX has an Overall Score of 59. Find out what this means to you and get the rest of the rankings on IRIX!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 59 means the stock is more attractive than 59 percent of stocks. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With IRIDEX Corporation Stock Today?

IRIDEX Corporation (IRIX) stock has risen 1.96% while the S&P 500 has fallen -0.24% as of 10:40 AM on Tuesday, Sep 5. IRIX is higher by $0.04 from the previous closing price of $1.79 on volume of 18,205 shares. Over the past year the S&P 500 has gained 15.27% while IRIX has fallen -26.61%. IRIX lost -$0.49 per share the over the last 12 months. Click Here to get the full Stock Report for IRIDEX Corporation stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App